E. coli exposed! by Holton, W Conard
InnovationsR
ecent decades have seen new
microbial pathogens emerge
to threaten human health, especially
the health of children. With their
lower body weight and immature
immune systems, children are more
vulnerable than adults to food-
borne illnesses caused by the likes
of Campylobacter,
Salmonella, Listeria
monocytogenes, and
Escherichia coli O157:H7. In the
battle to identify contaminated food
and the sources of these pathogens,
many research efforts have focused
on E. coli O157:H7, which causes
some of the most severe symptoms
of foodborne illness in children and
has been identified as the source
of several major dis-
ease outbreaks in
the United States.
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PAs evidence of the dangers of E. coli
O157:H7 has mounted, the search for
technologies to rapidly detect and quanti-
fy the bacterium has also intensified. As
few as 10 E. coli O157:H7 bacteria can
cause illness, so sen-
sitivity to low num-
bers or the ability to
amplify cell numbers
quickly to detectable
levels are highly de-
sirable traits of any
testing method. Be-
fore testing can be
done, most current
clinical test methods require an enrich-
ment period of at least 8 hours, during
which the sample is placed in a nutritional
culture medium or environment so that
small numbers of the cells will multiply to
a detectable quantity. But separate efforts
by researchers at Cornell University and
the U.S. Department of Agriculture are
building on existing molecular technolo-
gies to improve test speed and sensitivity,
and produce a simple, potentially low-cost
field screening device.
Long Existence, Short History
E.coli is a normal inhabitant of the
intestines of all animals, including
humans. It serves a useful function in the
body by suppressing the growth of
harmful bacteria and by synthesizing vita-
mins. The Centers for Disease Control
and Prevention (CDC) discovered the
subgroup, or serotype, E. coli O157:H7 in
1975, but it wasn’t until 1982 that it was
conclusively linked to enteric diseases.
Outbreaks of E. coli O157:H7–related
disease have been recorded worldwide.
E. coli O157:H7 achieved notoriety in
1993, when undercooked contaminated
hamburger from the Jack In The Box
restaurant chain caused over 700 people,
primarily children, to become ill and 4
people to die. Since then, the safety of
ground beef has been a concern to health
officials, the food industry, and con-
sumers. This past summer, for example,
ConAgra Foods recalled 19 million
pounds of potentially contaminated
ground beef after an E. coli O157:H7 out-
break affected more than 35 people. The
CDC estimates that the overall number of
people sickened in the United States each
year by E. coli O157:H7 is approximately
73,000, although the incidence of report-
ed cases has decreased somewhat.
A primary source of E. coli O157:H7
is the gastrointestinal tract of cattle. The
bacterium is transmitted to humans in
part by bovine feces, which can taint water
used to irrigate crops and can also contam-
inate meat through improper food han-
dling during processing. E. coli O157:H7
outbreaks or sporadic cases have been
linked to drinking water, salad bar items,
salami, yogurt, and apple juice
and cider, the latter of which may
have been contaminated when
apples on the ground came in
contact with manure. In addition,
children have become infected
after swimming in contaminated
water. In 1998, an E. coli O157:H7 out-
break at an Atlanta, Georgia, water park
hospitalized several children.
Although many cases of foodborne ill-
nesses are acute, they tend to last a short
time, and only a few result in extended ill-
nesses. With E. coli O157:H7, the incuba-
tion period is usually 3–5 days. The bac-
terium produces toxins that result in
abdominal cramps, vomiting, often
bloody diarrhea, and sometimes fever. In
some acute cases, the infection will devel-
op into hemolytic uremic syndrome
(HUS), which is characterized by the
destruction of red blood cells, kidney fail-
ure, and potentially seizures, stroke, and
death. In the elderly, HUS can combine
with fever and other symptoms to produce
the HUS-like blood disorder thrombotic
thrombocytopenic purpura, with a mor-
tality rate at high as 50%.
Children—notably those younger than
4 or 5 years—are at relatively high risk for
infection, with E. coli O157:H7 possibly
the leading cause of acute kidney failure
and HUS in young children and infants.
According to the CDC, the infection rate
for E. coli O157:H7 is 6.1 per 100,000
infants and 8.2 per 100,000 children aged
1–9 years. This is the highest infection
rate of any age group. 
Micro-Approach to a Big Problem
At Cornell University’s Food Research
Laboratory in Geneva, New York, chem-
istry professor Richard Durst has been
working on using liposomes to deliver
markers that reveal the presence of E. coli
O157:H7 and other pathogens in food
samples. Liposomes are spherical
nanoscale structures composed of a two-
layer phospholipid/cholesterol shell that
can encapsulate a variety of different
markers, from fluorescent dyes to elec-
troactive compounds. Because the shell of
the liposome consists of chemically reac-
tive elements, various surface tags can be
attached, including antibodies, antigens,
oligonucleotide probes, and cell receptors. 
Durst says, “With so much flexibility
in what we can attach or encapsulate,
there are numerous different formats we
can use. We’ve developed formats in the
form of dipsticks similar to home preg-
nancy tests, optically based lateral-flow
systems, fluorescence-based tests, and
microfluidic devices. As long as you have
an antibody, gene probe, or natural recep-
tor, you can make a bioanalytic sensor
with this [liposome] technology.”
In a simple paper strip test, antibodies
are attached to the outer shell of the lipo-
some and bind to E. coli O157:H7 in the
sample when mixed together. The lipo-
somes contain dye molecules that clearly
mark the pathogens—as the sample liquid
is drawn up the paper strip, the paper
turns red if E. coli O157:H7 is present.
The quantity of bacteria present is then
estimated by optically measuring the color
intensity, which is proportional to the
pathogen population. 
The microcassette-size device can
detect large numbers of E. coli O157:H7
in under 10 minutes, although several
hours are required for single-pathogen
detection. Existing technologies can also
quickly identify the bacteria, but only
after an 8-hour culture amplification time
to produce a detectable count of 105 or
106 bacteria. “Because each liposome
contains hundreds of thousands to per-
haps millions of marker molecules, there
is a large amplification effect,” says
Durst. “Since detection and signal ampli-
fication using liposome labels are not
dependent on a secondary reaction—as
required in conventional enzyme-based
tests—the use of liposomes can provide
almost immediate warning of the pres-
ence of a pathogen.”
The technology has been investigated
for detecting chemical and biological war-
fare agents, naturally occurring pathogens
such as the parasite Cryptosporidium
parvum, viruses such as herpes, and natural
toxins such as botulinum. Independent
field testing of the device, sponsored by
the New York State Energy Research and
Development Authority, is now under way
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Gotcha! Immunoliposomes tag and identify
E. coli (left), while test strips show positive and
negative results (right).
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through a county public health laboratory. 
Antje Baeumner, a former postdoctor-
al fellow of Durst’s who is now an assis-
tant professor in the Department of
Biological and Environmental Engineer-
ing at Cornell, is developing a comple-
mentary detection technology in which
liposomes are used in conjunction with a
microfluidics-based biosensing system.
The technology of microfluidics encom-
passes devices and processes that deal
with very low quantities—usually nano-
liters—of fluids. This scale changes the
behavior of systems, including the capil-
lary action by which fluids pass through
channels. So with very small channels,
liquid can be controlled in new and use-
ful ways. Baeumner’s goal in this case is
to create a micro–Total Analysis System
(µ-TAS), a “lab-on-a-chip” containing
automated microchannels that perform
all the steps necessary, including sample
preparation, amplification, and electro-
chemical detection and quantification of
pathogens—all on a device the size of a
handheld computer.
In one of the µ-TAS component chips,
she uses liposomes encapsulating an elec-
troactive couple (an oxidized and reduced
form of the same molecule). This molecule
is used instead of a visible marker to indi-
cate targets such as E. coli O157:H7. In a
chamber on the chip, nanoscale cathode
and anode pads with interlocking fingers
alternately oxidize and then reduce
the couple repeatedly. As this oxida-
tion–reduction reaction continues, the
resulting electron flow through the micro-
electrodes can be easily monitored, and the
magnitude of the signal is directly propor-
tional to the concentration of E. coli
O157:H7 present.
The technologies under development
by Durst and Baeumner are being evaluated
by several large companies and government
agencies. The licensing arrangements, field
trials, and potential commercialization of
the technologies are handled through the
offices of Innovative Biotechnologies Inter-
national. Richard Montagna, the compa-
ny’s president, says a commercial biosensor
for C. parvum should be available in early
2003, while one for E. coli O157:H7 is
about a year away.
The Shape of Assays to Come
Other weapons against E. coli O157:H7
are in earlier phases of development. For
example, at the U.S. Department of
Agriculture’s Animal Waste Pathogen
Laboratory in Beltsville, Maryland, micro-
biologist Daniel Shelton is working on a
method to quickly identify and quantify
E. coli O157:H7 in both natural and con-
structed bodies of water. 
Shelton is using magnetic beads coated
with anti–E. coli O157:H7 monoclonal
antibodies to bind to the bacterium. He is
not ready to reveal the specific culture
medium, but he says it provides a very fast
means of growing detectable levels of the
bacterium—a day or less—whereas tradi-
tional water testing can take up to four
days. This method will allow identification
of 1 E. coli O157:H7 bacterium in 100
milliliters of water, and should help health
officials check public water sites such as
swimming pools. 
Shelton says magnetic bead technolo-
gy is not new—commercially available
immunoassay kits already use magnetic
beads to deliver chemical markers for all
different purposes. But Shelton’s method
is unique in the rapidity with which the
user will be able to quantify E. coli
O157:H7 in a sample. Plus, most other
research efforts have focused on detecting
the contaminant in food, rather than
water. None of Shelton’s research has
been published yet, and he is still waiting
on results from current studies, but the
water treatment industry and public
water works agencies have shown interest
in his work. 
However, acceptance of these new
techniques will come only if they prove
themselves over time, according to
Michael Doyle, a professor of food
microbiology and head of the Center for
Food Safety at the University of
Georgia, who has conducted his own
developmental work on detecting E. coli
O157:H7. Doyle notes that the biggest
and an often overlooked challenge in
developing any fast detection method is
the fact that a large portion of the E. coli
O157:H7 population in any sample is
often damaged by heat, freezing, or
chlorine in the water.
Doyle says the only way to ensure
that all E. coli O157:H7 are counted is
to give them a long enough incubation
period to allow them to revive, which is
what they would do inside the human
body. Durst agrees, but adds that his
method is based on high sensitivity to
low numbers of organisms and will
quickly detect, though perhaps not accu-
rately quantify, E. coli O157:H7 even if
large numbers of the organism are dor-
mant. He says, “Our liposome immuno-
assay detection limit without enrichment
is about one thousand target organisms
per milliliter or gram. Most immuno-
based assays require the presence of at
least ten to one hundred thousand cells
of the target organism per milliliter or
gram for detection. Consequently, with
this ten- to one hundred–fold increase in
sensitivity, we require only about a three-
hour enrichment to achieve a less-than-
one-target-organism-per-milliliter or -gram
detection.”
The food industry would like to make
use of these technologies and applauds
their development for testing both food
and water. Yet there is more that should
be done. Jenny Scott, senior director of
Food Safety Programs at the National
Food Processors Association, a Wash-
ington, D.C.–based trade association,
says that testing is only part of the answer
to the threat posed by E. coli O157:H7.
“There are limitations with any testing
method,” she says. “No matter how good,
it’s never good enough.”
According to Scott, the entire food
chain from farm to kitchen must be
addressed, with consumers educated
about the need to cook food long enough
to kill bacteria and the potential value of
food irradiation. Other key steps are to
properly handle and test food during pro-
cessing, and to start with good farm prac-
tices and science, such as controlling
manure properly and possibly developing
a vaccine for E. coli O157:H7 in cattle. 
W. Conard Holton
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